Further correlation ofA2AR engagement and downstream signaling was done in ahuman blood translational assay, clearly showcasing the potentialof A2AR allosteric modulation as a novel approach for efficientand safer cancer immunotherapies. The gene discussed is ADORA2A; the disease is cancer.